The DNA Way

While there are various screening tools to detect colorectal cancer, people skip them due to expense, the uncomfortable nature of the screen, having to take time off work, or having to handle stool samples, the New York Times' Well blog says. It adds that researchers are working on developing other screening tools that may be better tolerated by patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Don't Chew The Pills!

The Screening Test

iPad Eye Scan

A Fraud Blockbuster

This Week in PNAS

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.